Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
information from participants to study how genes, lifestyle and our environment may lead to cancer. The BioBank serves as a valuable resource for researchers at The University of Kansas Cancer Center and
-
to: Testing the phage therapy efficacy in humanized mouse model, characterizing the immune responses, safety, toxicity and biodistribution in humanized mice. HIV gene therapy: depending on the interest and
-
on 1 January 2024 and focuses on research and development of cell and gene therapy for selected rare diseases. The CZECRIN Large Research Infrastructure (LRI) is a Czech national infrastructure
-
for ADPKD. Gene therapy based on adeno-associated viruses (AAVs) holds the promise of offering a long-term curative approach for ADPKD. In this project, the PhD researcher will develop an AAV-mediated gene
-
psychological well-being is both a vulnerability factor for the onset of EDs and an area of persistent difficulty even after evidence-based treatments, suggesting that symptom remission does not necessarily mean
-
Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences | Poland | about 1 month ago
of Recruitment Processes for Scientific Positions at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. Recruitment documentation is available at https
-
functional readouts. The project will be conducted in close collaboration with international experts in gene therapy and muscle pathology. This project combines mechanistic cell biology with translational gene
-
regulatory affairs and quality assurance efforts of the Center for Cellular Immunotherapies (CCI). This role will ensure cGMP quality and compliance to release of investigational cell and gene therapy products
-
for the following position as civil servant or public employee starting as soon as possible: Professor (W2) of Stem Cell Transplantation, Cellular and Gene Therapy The professorship is based within the Department
-
at bringing CaV1.3-RNAi gene therapy to patients with PD. A Research Assistant I (RAI) is expected to participate in the multi-disciplinary approaches used in our lab including, but are not limited